Withania somnifera (L.) Dunal: Phytochemistry, structure-activity relationship, and anticancer potential
Devesh Tewari1, Vikas Chander2, Archana Dhyani3
1Department of Pharmacognosy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Ashwagandha (Withania somnifera) shows significant anticancer potential, particularly its compounds like withaferin A. Further clinical trials are needed to confirm its therapeutic application in cancer treatment.
Area of Science:
- Phytochemistry
- Pharmacology
- Traditional Medicine
Background:
- Ayurveda utilizes numerous plants for health preservation and disease mitigation.
- Withania somnifera (Ashwagandha), or Indian Ginseng, is a key Ayurvedic plant with diverse therapeutic effects.
- Its anticancer properties are of significant interest for modern medicine.
Purpose of the Study:
- To provide a comprehensive review of the anticancer effects of Withania somnifera.
- To elucidate the mechanistic actions of its bioactive phytocompounds, focusing on withanolides.
- To update information on clinical studies, safety, and chemical modification opportunities for withanolides.
Main Methods:
- Systematic review conducted following PRISMA guidelines.
- Literature search performed across major scientific databases (PubMed, Science Direct, Scopus, Google Scholar) up to May 2021.
- Focus on studies detailing anticancer potential, mechanisms, and clinical attributes.
Main Results:
- Withania somnifera exhibits notable anticancer potential, driven by bioactive components like withanolides, withaferin A, and withanone.
- Structure-activity relationship (SAR) and toxicity evaluations of key compounds are presented.
- Clinical attributes and updated information on W. somnifera's role in cancer are detailed.
Conclusions:
- Withania somnifera demonstrates substantial promise for cancer therapy.
- Withanolides, especially withaferin A, show strong binding affinities, indicating potential as lead compounds for new drug development.
- Further rigorous clinical trials are essential to validate the therapeutic use of withanolides in cancer treatment.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...


